SILO PHARMA, INC. Other Notes Payable
SILO PHARMA, INC. (SILO) had Other Notes Payable of $81.47 thousand as of 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:OtherNotesPayable · last filed 2024-03-25
- 2023-12-31: Other Notes Payable $81.47K.
- 2023-09-30: Other Notes Payable $81.47K.
- 2023-06-30: Other Notes Payable $81.47K.
- 2023-03-31: Other Notes Payable $81.47K.
| Period end | Other Notes Payable |
|---|---|
| 2023-12-31 | $81.47K 10-K · filed 2024-03-25 |
| 2023-09-30 | $81.47K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $81.47K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $81.47K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $81.47K 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |